发布求助
文献互助 智能选刊 最新文献

European Journal of Cancer最新文献

筛选
英文 中文
The radiotherapy omission within the Sinodar One protocol: Survival and Relapse Outcomes and dosimetric analysis Sinodar One 方案中的放射治疗遗漏：生存和复发结果及剂量分析
European Journal of Cancer Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113720
R. Spoto, A. Bertolini, D. Franceschini, L. Dominici, F. Lobefalo, C. Tinterri, M. Scorsetti
{"title":"The radiotherapy omission within the Sinodar One protocol: Survival and Relapse Outcomes and dosimetric analysis","authors":"R. Spoto, A. Bertolini, D. Franceschini, L. Dominici, F. Lobefalo, C. Tinterri, M. Scorsetti","doi":"10.1016/j.ejca.2024.113720","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113720","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"100 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metronomic treatment significantly enhanced cytotoxicity in palbociclib-resistant ER-positive breast cancer cell lines 配伍治疗可明显增强帕博西尼（palbociclib）耐药ER阳性乳腺癌细胞系的细胞毒性
European Journal of Cancer Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113825
N. Sherif, A. Ilari, N. Cordani, E. Grassilli, M.E. Cazzaniga, M. Lavitrano, M. Cerrito
{"title":"Metronomic treatment significantly enhanced cytotoxicity in palbociclib-resistant ER-positive breast cancer cell lines","authors":"N. Sherif, A. Ilari, N. Cordani, E. Grassilli, M.E. Cazzaniga, M. Lavitrano, M. Cerrito","doi":"10.1016/j.ejca.2024.113825","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113825","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"225 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world analysis of genomic signature indications and impact on adjuvant chemoendocrine therapy (CET) decisions: experience from the French LISE cohort (n = 301) 基因组特征适应症及其对辅助化疗内分泌疗法 (CET) 决策影响的实际分析：来自法国 LISE 队列（n = 301）的经验
European Journal of Cancer Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113867
B. Cutuli, C. Charles, F. Bancheri, Y. Caron, D. Coeffic, P. Colin, P.H. Dorangeon, S. Ferrand, N. Gavillon, C.G. Hemery, N. Jovenin, L. Krebs, A.R. Majidi, F. Mallet, W. Mina, K. Prulhiere-Corviole, P. Terrosi, A. Theillier, I. Veron-Leclercq, G. Yazbek
{"title":"Real-world analysis of genomic signature indications and impact on adjuvant chemoendocrine therapy (CET) decisions: experience from the French LISE cohort (n = 301)","authors":"B. Cutuli, C. Charles, F. Bancheri, Y. Caron, D. Coeffic, P. Colin, P.H. Dorangeon, S. Ferrand, N. Gavillon, C.G. Hemery, N. Jovenin, L. Krebs, A.R. Majidi, F. Mallet, W. Mina, K. Prulhiere-Corviole, P. Terrosi, A. Theillier, I. Veron-Leclercq, G. Yazbek","doi":"10.1016/j.ejca.2024.113867","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113867","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"76 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140279377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Congruence of Tumor Characteristics between Preoperative Biopsy and Surgical Excision Specimen for Small Breast Tumors: CONSCIENCE 小型乳腺肿瘤术前活检与手术切除标本的肿瘤特征一致性：一致性
European Journal of Cancer Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113788
S. Wooldrik
{"title":"Congruence of Tumor Characteristics between Preoperative Biopsy and Surgical Excision Specimen for Small Breast Tumors: CONSCIENCE","authors":"S. Wooldrik","doi":"10.1016/j.ejca.2024.113788","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113788","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"241 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140280271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-World Comparison of Overall Survival in Female Patients with HR+/HER2- Metastatic breast cancer receiving endocrine therapy, endocrine therapy plus palbociclib, or chemotherapy 接受内分泌治疗、内分泌治疗加帕博西尼或化疗的 HR+/HER2- 转移性乳腺癌女性患者总生存期的真实世界比较
European Journal of Cancer Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113714
U. Rizwan, R. Hussain, G. Kanagala
{"title":"Real-World Comparison of Overall Survival in Female Patients with HR+/HER2- Metastatic breast cancer receiving endocrine therapy, endocrine therapy plus palbociclib, or chemotherapy","authors":"U. Rizwan, R. Hussain, G. Kanagala","doi":"10.1016/j.ejca.2024.113714","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113714","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"114 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140280882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine learning model predicting axillary pathologic response after neoadjuvant chemotherapy for clinically node-positive breast cancer 预测临床结节阳性乳腺癌新辅助化疗后腋窝病理反应的机器学习模型
European Journal of Cancer Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113742
A. Matsumoto, M. Sugimoto, S. Naruse, Y. Isono, Y. Maeda, A. Sato, M. Yamada, T. Ikeda, H. Jinno
{"title":"Machine learning model predicting axillary pathologic response after neoadjuvant chemotherapy for clinically node-positive breast cancer","authors":"A. Matsumoto, M. Sugimoto, S. Naruse, Y. Isono, Y. Maeda, A. Sato, M. Yamada, T. Ikeda, H. Jinno","doi":"10.1016/j.ejca.2024.113742","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113742","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"518 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140281757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), through an innovative virus-like particles (VLP)-based vaccine, enhance the antitumoral activity of a HER-2-VLP vaccine in a preclinical model of HER-2 positive breast cancer 通过基于病毒样颗粒 (VLP) 的创新疫苗，靶向 9 型枯草蛋白酶/kexin (PCSK9)，提高 HER-2 阳性乳腺癌临床前模型中 HER-2-VLP 疫苗的抗肿瘤活性
European Journal of Cancer Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113822
F. Ruzzi, L. Scalambra, M. S. Semprini, O. M. Pittino, C. Cappello, S. Angelicola, A. Palladini, P. Nanni, C. Fougeroux, L. Goksøyr, A.F. Sander, P.L. Lollini
{"title":"Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), through an innovative virus-like particles (VLP)-based vaccine, enhance the antitumoral activity of a HER-2-VLP vaccine in a preclinical model of HER-2 positive breast cancer","authors":"F. Ruzzi, L. Scalambra, M. S. Semprini, O. M. Pittino, C. Cappello, S. Angelicola, A. Palladini, P. Nanni, C. Fougeroux, L. Goksøyr, A.F. Sander, P.L. Lollini","doi":"10.1016/j.ejca.2024.113822","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113822","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"213 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140282206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive value of contrast enhanced spectral mammography (CESM) and mammotome guided biopsy of clipped tumour in determining pathological complete response following neoadjuvant chemotherapy in breast cancer patients 乳腺癌患者新辅助化疗后，对比增强光谱乳腺 X 射线造影术 (CESM) 和乳腺切片引导下的肿瘤切片检查在确定病理完全反应方面的预测价值
European Journal of Cancer Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113859
S.S.H. Phua, P. Chan, E.Y. Tan, J. Chen, E.J. Sim
{"title":"Predictive value of contrast enhanced spectral mammography (CESM) and mammotome guided biopsy of clipped tumour in determining pathological complete response following neoadjuvant chemotherapy in breast cancer patients","authors":"S.S.H. Phua, P. Chan, E.Y. Tan, J. Chen, E.J. Sim","doi":"10.1016/j.ejca.2024.113859","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113859","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"156 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140282234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The incidence of male breast cancer in Klinefelter’s syndrome and its proposed mechanisms 克莱因费尔特综合征男性乳腺癌的发病率及其拟议机制
European Journal of Cancer Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113885
B. Cook, S. Nayar
{"title":"The incidence of male breast cancer in Klinefelter’s syndrome and its proposed mechanisms","authors":"B. Cook, S. Nayar","doi":"10.1016/j.ejca.2024.113885","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113885","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140271439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of HER2-low breast cancer in Lithuania 立陶宛 HER2 低水平乳腺癌流行病学
European Journal of Cancer Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113843
A. Cesas, L. Poskiene, R.B. Valkiuniene, L. Radvinskiene, I. Lege
{"title":"Epidemiology of HER2-low breast cancer in Lithuania","authors":"A. Cesas, L. Poskiene, R.B. Valkiuniene, L. Radvinskiene, I. Lege","doi":"10.1016/j.ejca.2024.113843","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113843","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"52 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140274591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信